ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,416.90
0.51%
S&P ASX All Technology
3,999.30
1.15%
Brent Oil
75.305
-0.84%
US Dollar vs AUD
1.59147
-0.52%
Bitcoin
97,939.02
0.08%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Pluxee NV (PLX) Share Price

Pluxee NV

Pluxee NV (PLX)

Protalix BioTherapeutics Inc
Pyrolyx AG
Point Loma Resources Ltd
22.685
-0.315
( -1.37% )
Updated: 22:15:33
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
22.685
Bid
22.67
Offer
22.715
Volume
31,236
22.63 Day's Range 23.18
15.214 52 Week Range 31.82
Market Cap
3.339B
Previous Close
23.00
Open
22.90
Last Trade
118
@
22.685
Last Trade Time
22:15:11
Financial Volume
-
VWAP
-
Average Volume (3m)
124,327
Shares Outstanding
147,174,692
Dividend Yield
3.09%
PE Ratio
25.45
Earnings Per Share (EPS)
0.9
Revenue
1.21B
Net Profit
133M

About Pluxee NV

Sector
Employment Agencies
Industry
Employment Agencies
Website
www.pluxeegroup.com
Headquarters
Issy-les-moulineaux, Hauts-de-seine, Fra
Founded
-
Pluxee NV is listed in the Employment Agencies sector of the Euronext with ticker PLX. The last closing price for Pluxee NV was 23.00 €. Over the last year, Pluxee NV shares have traded in a share price range of 15.214 € to 31.82 €.

Pluxee NV currently has 147,174,692 shares in issue. The market capitalisation of Pluxee NV is 3.39 € billion. Pluxee NV has a price to earnings ratio (PE ratio) of 25.45.

Ask ADVFN Intelligence (AI)

PLX Latest News

More News

Half-year report on the liquidity contract as of December 31, 2024

Half-year report on the liquidity contract as of December 31, 2024 Half-year report on the liquidity contract as of December 31, 2024Issy-les-Moulineaux, France – January 9, 2025 Regulated...

09 January 2025
UK Regulatory

Bilan semestriel du contrat de liquidité au 31 décembre 2024

Bilan semestriel du contrat de liquidité au 31 décembre 2024 Bilan semestriel du contrat de liquidité au 31 décembre 2024Issy-les-Moulineaux, France – 9 janvier 2025 Information réglementée Bilan...

09 January 2025
UK Regulatory

Chiffre d’affaires du 1er trimestre de l’exercice fiscal 2025

Chiffre d’affaires du 1er trimestre de l’exercice fiscal 2025 Chiffre d’affaires du 1er trimestre de l’exercice fiscal 2025  Un début d’année solide, en ligne avec les objectifs stratégiques...

08 January 2025
UK Regulatory

Fiscal Q1 2025 Revenues

Fiscal Q1 2025 Revenues Fiscal Q1 2025 Revenues Issy-les-Moulineaux, France – January 8th, 2025 A robust start to the year, in line with the Group's strategic and financial objectives Highlights...

08 January 2025
UK Regulatory

Résultats de l’Assemblée générale annuelle d’actionnaires pour l’exercice 2024

Résultats de l’Assemblée générale annuelle d’actionnaires pour l’exercice 2024 Résultats de l’Assemblée générale annuelle d’actionnaires pour l’exercice 2024 Amsterdam-Schiphol : 18 décembre...

19 December 2024
UK Regulatory

Voting results of the Fiscal 2024 Annual General Meeting of Pluxee

Voting results of the Fiscal 2024 Annual General Meeting of Pluxee Voting results of the Fiscal 2024 Annual General Meeting of Pluxee Amsterdam-Schiphol, December 18, 2024 //  Pluxee N.V...

19 December 2024
UK Regulatory

Pluxee acquires Beneficio Facil in Brazil and reinforces its employee mobility offer

Pluxee acquires Beneficio Facil in Brazil and reinforces its employee mobility offer Pluxee acquires Benefício Fácil in Brazil and reinforces its employee mobility offer  Pluxee to reinforce its...

29 November 2024
UK Regulatory

Pluxee renforce son offre mobilité pour les salariés au Brésil avec l’acquisition de Benefício Fácil

Pluxee renforce son offre mobilité pour les salariés au Brésil avec l’acquisition de Benefício Fácil Pluxee renforce son offre mobilité pour les salariés au Brésil avec l’acquisition de Benefício...

29 November 2024
UK Regulatory

Pluxee convenes its Fiscal 2024 Annual General Meeting of shareholders

Pluxee convenes its Fiscal 2024 Annual General Meeting of shareholders Pluxee convenes its Fiscal 2024 Annual General Meeting of shareholders Paris: November 6, 2024 // Today, Pluxee announced the...

06 November 2024
UK Regulatory

Pluxee convoque son Assemblée générale annuelle d’actionnaires pour l’exercice 2024

Pluxee convoque son Assemblée générale annuelle d’actionnaires pour l’exercice 2024 Pluxee convoque son Assemblée générale annuelle d’actionnaires pour l’exercice 2024 Paris : 6 novembre 2024 //...

06 November 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.1750.77743225233222.5123.1821.68512030222.54782582DE
42.75513.823381836419.9323.1819.513048822.32136875DE
122.91114.721351269319.77423.1817.9612432720.54142028DE
262.88314.559135440919.80223.1815.21413976719.57479326DE
52-6.7-22.800748681329.38531.8215.21421639124.47295149DE
156-5.815-20.403508771928.531.8215.21425005225.22422201DE
260-5.815-20.403508771928.531.8215.21425005225.22422201DE

PLX - Frequently Asked Questions (FAQ)

What is the current Pluxee NV share price?
The current share price of Pluxee NV is 22.685 €
How many Pluxee NV shares are in issue?
Pluxee NV has 147,174,692 shares in issue
What is the market cap of Pluxee NV?
The market capitalisation of Pluxee NV is EUR 3.39B
What is the 1 year trading range for Pluxee NV share price?
Pluxee NV has traded in the range of 15.214 € to 31.82 € during the past year
What is the PE ratio of Pluxee NV?
The price to earnings ratio of Pluxee NV is 25.45
What is the cash to sales ratio of Pluxee NV?
The cash to sales ratio of Pluxee NV is 2.8
What is the reporting currency for Pluxee NV?
Pluxee NV reports financial results in EUR
What is the latest annual turnover for Pluxee NV?
The latest annual turnover of Pluxee NV is EUR 1.21B
What is the latest annual profit for Pluxee NV?
The latest annual profit of Pluxee NV is EUR 133M
What is the registered address of Pluxee NV?
The registered address for Pluxee NV is 16 RUE DU PASSEUR DE BOULOGNE, ISSY-LES-MOULINEAUX, HAUTS-DE-SEINE, 92130
What is the Pluxee NV website address?
The website address for Pluxee NV is www.pluxeegroup.com
Which industry sector does Pluxee NV operate in?
Pluxee NV operates in the EMPLOYMENT AGENCIES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALNMGNetMedia Group
2.34 €
(67.14%)
15.45k
ALAGOEPango SA
0.383 €
(20.44%)
4.94M
MLNMAMiguet Et Associes
0.08 €
(14.29%)
415
ALMASMastrad
0.0262 €
(13.91%)
10.99M
ALRGRRougier
17.80 €
(10.56%)
3.69k
BIODSBiosynex DS
0.0079 €
(-61.84%)
241.77k
ALNEVNeovacs
0.22 €
(-24.14%)
83.32k
ALTROTronic s Microsystems
4.10 €
(-23.36%)
39
ALVIOValerio Therapeutics
0.0618 €
(-20.46%)
1.05M
TUVDSBio UV Group DS
0.04 €
(-20.00%)
1.03M
ATOAtos SE
0.0021 €
(0.00%)
55.07M
BCPBanco Comercial Portugues SA
0.4933 €
(-0.22%)
23.04M
ALMASMastrad
0.0262 €
(13.91%)
10.99M
ALNRGEnergisme SA
0.0034 €
(6.25%)
6.06M
ALHPIHopium SA
0.003 €
(3.45%)
5.02M

Discussion

View Full Feed
RobotDroid RobotDroid 1 minute ago
It's where the dummies congregate.
NWBO
nwsun nwsun 3 minutes ago
Looking at a 5 year chart of this stock it looks like a bear etf.
ADTX
budfoxfun budfoxfun 4 minutes ago
"With our global patents and pending patents, we are revolutionizing environmental solutions for a sustainable future." https://thesustainablegreenteam.com/sgtm-home-page
SGTM
RobotDroid RobotDroid 4 minutes ago
Dream on, this will never ever happen.
NWBO
DoubleDouble DoubleDouble 4 minutes ago
https://investorshub.advfn.com/uimage/uploads/2025/2/5/nxjmuIMG_2977.jpeg
YBCN
WojD40 WojD40 6 minutes ago
Blame them for what? The ‘delay’ in a process that varies wildly in scope and complexity and was never assigned a deadline in the first place? I imagine the MAA is at least as complicated as building a house. How often does that happen ‘on time’? The company doesn’t update so as to avoid the kind of
NWBO
exwannabe exwannabe 6 minutes ago
• Drugs appearing on this list are typically those that are already approved or are expected to receive regulatory approval soon.
...
• If Mircidencel is still in the regulatory approval process, its inclusion in NHS documentation could indicate that approval is anticipated.
...
NWBO
floblu14 floblu14 7 minutes ago
Barbara Fiacco is a lawyer representing Enanta, correct? CORRECT!
She has represented leading pharmaceutical and life sciences clients in significant patent infringement lawsuits that have resulted in summary judgment or other favorable outcomes for her clients.

Also,
D
ENTA
Capt Caveman Capt Caveman 9 minutes ago
short volume percentage
10.61% 2-4-25

OTCShortReport.com

DBMM
DBMM
The ELTP King The ELTP King 10 minutes ago
********** NEW! **********

LOXAPINE SUCCINATE
ANDA #076868 SUPPL-12
ELITE LABS INC
Status: Labeling Approval

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076868
ELTP
TechandBio TechandBio 10 minutes ago
Should see the 60's! core holding in my IRA was $7.00 not that long ago need the foresight to really hit these home runs!
AKRO
jordan95 jordan95 12 minutes ago
They have a new post on x about this deal they're announcing I left a comment about the dilution happening
ASII
10thMountain 10thMountain 13 minutes ago
It needs a good catalyst. One with substance, and no fluff
FDCT
shadolane shadolane 14 minutes ago
Thank you for your reply.
AMRN
KenKong KenKong 16 minutes ago
style="caret-color: rgb(34, 34, 34); color: rgba(34, 34, 34, 1); font-family: Roboto, "Helvetica Neue", Helvetica, Arial, sans-serif; background-color: rgba(255, 255, 255, 1)""Critical projects in Alaska like Ambler Road and Pebble Mine and oil and gas exploration in ANWR which are held up by radica
NAK
rolvram rolvram 17 minutes ago
Deepseek is lying and used 5k H-100
NVDA
TechandBio TechandBio 17 minutes ago
Fat synthesizer oral drug best in class SGMT Break through designation can apply for approval with Phase 3 after 1 year if the data follows their phase2b readout. Tam for Mash and Obesity will be over a quarter trillion in the coming years.


Pediatric Nash for SGMT i Pediatr
AKRO MDGL SGMT
Chiron Chiron 19 minutes ago
The exciting deal should see this hit .0006 and then collapse to .0003
ASII
PennMilitia PennMilitia 19 minutes ago
Fannie-Mae made 44m dollars-per-day / 3rd QTR

Hope those numbers keep coming in for the 4th QTR 2024.
FNMA
TechandBio TechandBio 20 minutes ago
Should double from here next 12-24 months. playing some options pretty far out.

$SMMT
SMMT
budfoxfun budfoxfun 21 minutes ago
Tony Raynor Teams Up With Fishing Legend Jimmy Houston to Showcase Organic Solutions for Food Security https://finance.yahoo.com/news/sustainable-green-team-unveils-revolutionary-165500864.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
SGTM
budfoxfun budfoxfun 21 minutes ago
Our patented technologies incorporates cutting-edge technologies like Biological Hydrosynthesis and Ecological Stem Cell Technology. It addresses key environmental issues on a global scale, including safe organic residue handling, viable topsoil replacement, and the addition of a third water source.
SGTM
theorysuit theorysuit 22 minutes ago
Oh blame the mhra.....this is the company mantra. Blame anyone but ourselves for this horrible execution. Update shareholders and stop blaming others and have some accountability for once in their pathetic existence.
NWBO

Your Recent History

EU
PLX
Pluxee NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads